IPO Trending
BLUEJETEQ / NSE, BSEListed

Blue Jet Healthcare Limited

Incorporated in 1968, Blue Jet Healthcare is a science-led pharmaceutical company specializing in healthcare ingredients and intermediates. The company was the first in India to manufacture saccharin and its salts and has since expanded into contrast media intermediates for CT scans and MRIs. Its main product categories include contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and APIs. Blue Jet Healthcare offers process development, production capabilities, global regulatory support, and collaboration in advanced pharmaceutical development. The company operates three manufacturing facilities in Shahad, Ambernath, and Mahad, Maharashtra, with annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively, as of June 30, 2023.

₹329 - ₹3467.94x sub
Listed Price380.00
Listing Gain+9.83%
Subscription7.94x total demandUpdated 05 Nov 2025, 10:16 AM
QIB13.72x
Hot Bidding (High Profits)Offered: 48,57,032 sh
Nib13.59x
Hot Bidding (High Profits)Offered: 36,42,774 sh
Hnis(10l +)15.65x
Hot Bidding (High Profits)Offered: 24,28,516 sh
Hnis (2-10l)9.46x
Popular / Warm DemandOffered: 12,14,258 sh
Retail2.22x
Fully Subscribed (Safe)Offered: 84,99,806 sh
CategoryOfferedAppliedTimes
QIB48,57,0326,66,51,24713.72x
Nib36,42,7744,94,99,70813.59x
Hnis(10l +)24,28,5163,80,08,04415.65x
Hnis (2-10l)12,14,2581,14,91,6649.46x
Retail84,99,8061,88,95,5332.22x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB2,306.13168.0513.72x
Retail653.79294.092.22x
Hnis 2+397.6142.019.46x
Hnis 10+1,315.0884.0315.65x
Application-wise Breakup
CategoryReservedAppliedTimes Sub.
N/a00Open